Your new experience awaits. Try the new design now and help us make it even better

CORRECTION article

Front. Chem., 23 January 2026

Sec. Medicinal and Pharmaceutical Chemistry

Volume 14 - 2026 | https://doi.org/10.3389/fchem.2026.1785599

This article is part of the Research TopicMedicinal and edible TCMs: Extraction and Isolation, Structural Elucidation, Pharmacological Evaluation, Structural Modification, and Quality ControlView all 20 articles

Correction: Preclinical evaluation of 6-Gingerol in modulating gut microbiota and SCFAs to mitigate Clostridium difficile-associated diarrhea in mice

  • 1Department of Pharmacy, Beijing Ditan Hospital, Capital Medical University, Beijing, China
  • 2Department of Pharmacy, Beijing Friendship Hospital, Capital Medical University, Beijing, China
  • 3College of Traditional Chinese Medicine, Yunnan University of Chinese Medicine, Kunming, Yunnan, China

A Correction on
Preclinical evaluation of 6-Gingerol in modulating gut microbiota and SCFAs to mitigate Clostridium difficile-associated diarrhea in mice

by Ma F-Z, Zhu L, Li M, Tang Z-W, Yu X-H, Zhang C-E and Ma Z-J (2025). Front. Chem. 13:1635781. doi: 10.3389/fchem.2025.1635781

The funder National Natural Science Foundation of China, grant number 82474163 to Zhijie Ma was erroneously omitted. The correct Funding statement reads:

The author(s) declared that financial support was received for this work and/or its publication. This work was supported by the National Key R&D Program of China (2023YFC2308200), the National Natural Science Foundation of China (No. 82474163), the National Natural Science Foundation of China (No. 82374053), and the Beijing Hospitals Authority High-Level Public Health Technical Talent Development Project (Code: Academic Leader-02-28). This support significantly contributed to the success of our research.

The original article has been updated.

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Keywords: 6-Gingerol, Clostridium difficile-associated diarrhea, pharmacodynamic evaluation, gut microbiota, short-chain fatty acids (SCFAs)

Citation: Ma F-Z, Zhu L, Li M, Tang Z-W, Yu X-H, Zhang C-E and Ma Z-J (2026) Correction: Preclinical evaluation of 6-Gingerol in modulating gut microbiota and SCFAs to mitigate Clostridium difficile-associated diarrhea in mice. Front. Chem. 14:1785599. doi: 10.3389/fchem.2026.1785599

Received: 12 January 2026; Accepted: 13 January 2026;
Published: 23 January 2026.

Approved by:

Frontiers Editorial Office, Frontiers Media SA, Switzerland

Copyright © 2026 Ma, Zhu, Li, Tang, Yu, Zhang and Ma. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Zhi-Jie Ma, bWF6ajIwMjFAMTYzLmNvbQ==; Cong-En Zhang, emNlODIwQDE2My5jb20=

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.